ECSP982588A - MODIFICATION OF A CRYSTAL OF A DERIVATIVE OF N-PHENYL -2-PIRIMIDINAMINE PROCESSES FOR ITS MANUFACTURE AND USE - Google Patents
MODIFICATION OF A CRYSTAL OF A DERIVATIVE OF N-PHENYL -2-PIRIMIDINAMINE PROCESSES FOR ITS MANUFACTURE AND USEInfo
- Publication number
- ECSP982588A ECSP982588A ECSP982588A ECSP982588A EC SP982588 A ECSP982588 A EC SP982588A EC SP982588 A ECSP982588 A EC SP982588A EC SP982588 A ECSP982588 A EC SP982588A
- Authority
- EC
- Ecuador
- Prior art keywords
- phenyl
- pirimidinamine
- derivative
- crystal
- modification
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 230000004048 modification Effects 0.000 title 1
- 238000012986 modification Methods 0.000 title 1
- -1 4-methylpiperazin-1-ylmethyl Chemical group 0.000 abstract 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 abstract 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 229940098779 methanesulfonic acid Drugs 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención se refiere a una nueva forma cristalina de la sal de adición de ácido metansulfónico de 4-(4-metilpiperazin-1-ilmetil)-N(4-metil -3-(4piridin -3-il)pirimidin -2-ilamino=fenil) benzamida de la fórmula I, que se puede utilizar, por ejemplo, para terapia de tumores.The invention relates to a novel crystalline form of the methanesulfonic acid addition salt of 4- (4-methylpiperazin-1-ylmethyl) -N (4-methyl -3- (4piridin -3-yl) pyrimidin -2-ylamino = phenyl) benzamide of formula I, which can be used, for example, for tumor therapy.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982588 ECSP982588A (en) | 1998-07-10 | 1998-07-10 | MODIFICATION OF A CRYSTAL OF A DERIVATIVE OF N-PHENYL -2-PIRIMIDINAMINE PROCESSES FOR ITS MANUFACTURE AND USE |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982588 ECSP982588A (en) | 1998-07-10 | 1998-07-10 | MODIFICATION OF A CRYSTAL OF A DERIVATIVE OF N-PHENYL -2-PIRIMIDINAMINE PROCESSES FOR ITS MANUFACTURE AND USE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP982588A true ECSP982588A (en) | 1999-03-02 |
Family
ID=42043508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP982588 ECSP982588A (en) | 1998-07-10 | 1998-07-10 | MODIFICATION OF A CRYSTAL OF A DERIVATIVE OF N-PHENYL -2-PIRIMIDINAMINE PROCESSES FOR ITS MANUFACTURE AND USE |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP982588A (en) |
-
1998
- 1998-07-10 EC ECSP982588 patent/ECSP982588A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4940418A1 (en) | MODIFICATION OF A CRYSTAL OF A DERIVATIVE OF N-PHENYL-2-PIRIMIDINAMINE, PROCESSES FOR ITS MANUFACTURE AND USE | |
| DE60317198D1 (en) | PROTEIN KINASE INHIBITORS | |
| BR0307351A (en) | Compound, pharmaceutical composition, method for treating a p38 kinase activity-mediated or cytokine-mediated condition or condition produced by p38 kinase activity, use of a compound, and process for preparing a compound | |
| ATE457025T1 (en) | KINASE INHIBITORS | |
| ATE260275T1 (en) | SUBSTITUTED THIEN-3-YL-SULFONYLAMINO(THIO)CARBONYL-TRIAZOLINE(THI)ONE | |
| UY26454A1 (en) | 4-CARBOXAMINE-1,2,3,4-TETRAHYDROKINOLINE 2-SUBSTITUTED CRYSTAL | |
| UY27852A1 (en) | DIFENILAZATIDINONAS CATIONICAMENTE REPLACED, PROCEDURE FOR PREPARATION, MEDICINES THAT UNDERSTAND THESE COMPOUNDS AND THEIR USE. | |
| UY27338A1 (en) | NEW DERIVATIVES OF SULPHONIC ACID | |
| AR045793A1 (en) | COMPOUNDS DERIVED FROM 3-HETEROCICLIL-INDOL | |
| BRPI0415203A (en) | restructured pentanols, a process for their production and use as anti-inflammatory agents | |
| CO5720995A2 (en) | NEW COMPOUND | |
| DK83789D0 (en) | SUBSTITUTED 1,2,4-TRIAZINDIONS, PROCEDURES AND INTERMEDIATES FOR THEIR MANUFACTURING AND THEIR USE | |
| DE60121587D1 (en) | CYCLIC GMP SPECIFIC PHOSPHODIESTERASE INHIBITORS | |
| SE0202461D0 (en) | Novel compounds | |
| ECSP982588A (en) | MODIFICATION OF A CRYSTAL OF A DERIVATIVE OF N-PHENYL -2-PIRIMIDINAMINE PROCESSES FOR ITS MANUFACTURE AND USE | |
| UY28498A1 (en) | CRYSTAL MODIFICATION OF A N-PHENYL-2-PYRIMIDINAMINE DERIVATIVE, PROCESSES FOR ITS MANUFACTURE AND USE. | |
| ECSP055692A (en) | PROCESS TO PREPARE INTERMEDIARIES | |
| UY27568A1 (en) | CRYSTAL DRUG FORM | |
| BR0312242A (en) | 4- (4-methylpiperazin-1-ylmethyl) -N- [4-methyl-3- (4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl] benzamide for the treatment of pulmonary fibrosis | |
| ES8504680A1 (en) | Benzamide derivatives | |
| DK1631291T3 (en) | Use of tyrosine kinase inhibitors to treat diabetes | |
| UY26251A1 (en) | CRYSTALLINE FORM III OF N- (4- (5- DIMETILAMINONAFTALEN-1- SULFONILAMINO) FENIL) -3 - HIDROXI-2, 2- DIMETILPROPIONAMIDA | |
| WO2004026930A3 (en) | The method for reducing inflammation using sti-571 or its salt | |
| BRPI0517388B1 (en) | Process for the preparation of phenyl 2-pyrimidinyl ketones and their intermediates | |
| BRPI0406970A (en) | Crystalline modification of a manganese complex |